New injection slows down early puberty in kids
NCT ID NCT05341115
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study tested a drug called leuprorelin to control central precocious puberty, a condition where children start puberty too early. About 80 children received an injection every 12 weeks for 6 months. The goal was to suppress hormones that drive early puberty, helping children develop at a more normal pace.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL PRECOCIOUS PUBERTY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Children's Hospital, Capital Medical University
Beijing, Beijing Municipality, 100033, China
-
Provincial Hospital Affiliated to Shandong First Medical University
Jinan, Shandong, 250021, China
-
Shanghai Children's Hospital
Shanghai, Shanghai Municipality, 200062, China
-
The Hospital attached by the Torigji Medical College, Huazhong Science and Technology University.
Wuhan, Hubei, 430030, China
-
the First A liated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510062, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.